loadpatents
name:-0.049438953399658
name:-0.028841972351074
name:-0.016874074935913
Picker; Louis Patent Filings

Picker; Louis

Patent Applications and Registrations

Patent applications and USPTO patent grants for Picker; Louis.The latest application filed is for "human cytomegalovirus comprising exogenous antigens".

Company Profile
17.17.27
  • Picker; Louis - Portland OR
  • Picker; Louis - Beaverton OR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
Grant 11,305,015 - Picker , et al. April 19, 2
2022-04-19
Recombinant HCMV and RHCMV vectors and uses thereof
Grant 11,266,732 - Picker , et al. March 8, 2
2022-03-08
Human Cytomegalovirus Comprising Exogenous Antigens
App 20220064225 - FRUEH; Klaus ;   et al.
2022-03-03
Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis
App 20210403951 - Evans; Thomas G. ;   et al.
2021-12-30
CMV Glycoproteins and Recombinant Vectors
App 20210395771 - PICKER; Louis ;   et al.
2021-12-23
Methods and compositions useful in generating non canonical CD8+ T cell responses
Grant 11,091,779 - Frueh , et al. August 17, 2
2021-08-17
Recombinant cytomegalovirus vectors as vaccines for tuberculosis
Grant 11,091,775 - Evans , et al. August 17, 2
2021-08-17
CMV Glycoproteins and Recombinant Vectors
App 20210222195 - PICKER; Louis ;   et al.
2021-07-22
Human cytomegalovirus comprising exogenous antigens
Grant 10,995,121 - Frueh , et al. May 4, 2
2021-05-04
Hiv Vaccines Comprising One Or More Population Episensus Antigens
App 20210046174 - Bruening; Eric ;   et al.
2021-02-18
Hiv Vaccines Comprising One Or More Population Episensus Antigens
App 20210046175 - Bruening; Eric ;   et al.
2021-02-18
HIV vaccines comprising one or more population episensus antigens
Grant 10,894,078 - Bruening , et al. January 19, 2
2021-01-19
Methods and Compositions Useful In Generating Non Canonical CD8+ T Cell Responses
App 20200392534 - FRUEH; Klaus ;   et al.
2020-12-17
Cmv Vectors Comprising Microrna Recognition Elements
App 20200368333 - NELSON; Jay ;   et al.
2020-11-26
CMV glycoproteins and recombinant vectors
Grant 10,760,097 - Picker , et al. Sep
2020-09-01
Cytomegalovirus Vectors Eliciting T Cells Restricted By Major Histocompatibility Complex E Molecules
App 20200237915 - PICKER; Louis ;   et al.
2020-07-30
CMV vectors comprising microRNA recognition elements
Grant 10,688,164 - Nelson , et al.
2020-06-23
Cytomegalovirus Vectors Enabling Control Of T Cell Targeting
App 20200140888 - Picker; Louis ;   et al.
2020-05-07
Human Cytomegalovirus Comprising Exogenous Antigens
App 20200102354 - FRUEH; Klaus ;   et al.
2020-04-02
Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
Grant 10,532,099 - Picker , et al. Ja
2020-01-14
Human cytomegalovirus comprising exogenous antigens
Grant 10,428,118 - Frueh , et al. October 1, 2
2019-10-01
Cmv Glycoproteins And Recombinant Vectors
App 20190211356 - Picker; Louis ;   et al.
2019-07-11
Cytomegalovirus vectors enabling control of T cell targeting
Grant 10,316,334 - Picker , et al.
2019-06-11
Recombinant Hcmv And Rhcmv Vectors And Uses Thereof
App 20190099479 - Picker; Louis ;   et al.
2019-04-04
Methods And Compositions Useful In Generating Non Canonical Cd8+ T Cell Responses
App 20180298404 - FRUEH; Klaus ;   et al.
2018-10-18
CMV glycoproteins and recombinant vectors
Grant 10,101,329 - Picker , et al. October 16, 2
2018-10-16
Human Cytomegalovirus Comprising Exogenous Antigens
App 20180282378 - Frueh; Klaus ;   et al.
2018-10-04
Recombinant HCMV and RHCMV vectors and uses thereof
Grant 9,982,241 - Picker , et al. May 29, 2
2018-05-29
Cytomegalovirus Vectors Eliciting T Cells Restricted By Majorhistocompatibility Complex E Molecules
App 20180133321 - Picker; Louis ;   et al.
2018-05-17
Cytomegalovirus Vectors Enabling Control Of T Cell Targeting
App 20180087069 - Picker; Louis ;   et al.
2018-03-29
Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis
App 20180016599 - Evans; Thomas G. ;   et al.
2018-01-18
CMV glycoproteins and recombinant vectors
Grant 9,862,972 - Picker , et al. January 9, 2
2018-01-09
Cmv Glycoproteins And Recombinant Vectors
App 20170350887 - Picker; Louis ;   et al.
2017-12-07
HIV Vaccines Comprising One or More Population Episensus Antigens
App 20170319679 - BRUENING; Eric E. ;   et al.
2017-11-09
Cytomegalovirus vectors enabling control of T cell targeting
Grant 9,783,823 - Picker , et al. October 10, 2
2017-10-10
Cmv Vectors Comprising Microrna Recognition Elements
App 20170143809 - Nelson; Jay ;   et al.
2017-05-25
CMV glycoproteins and recombinant vectors
Grant 9,541,553 - Picker , et al. January 10, 2
2017-01-10
Recombinant Hcmv And Rhcmv Vectors And Uses Thereof
App 20160114027 - Picker; Louis ;   et al.
2016-04-28
Recombinant HCMV and RHCMV vectors and uses thereof
Grant 9,249,427 - Picker , et al. February 2, 2
2016-02-02
Cytomegalovirus Vectors Enabling Control Of T Cell Targeting
App 20160010112 - Picker; Louis ;   et al.
2016-01-14
Cmv Glycoproteins And Recombinant Vectors
App 20140302530 - Picker; Louis ;   et al.
2014-10-09
Cmv Glycoproteins And Recombinant Vectors
App 20140141038 - Picker; Louis ;   et al.
2014-05-22
Cmv Glycoproteins And Recombinant Vectors
App 20130142823 - PICKER; Louis ;   et al.
2013-06-06
Recombinant HCMV and RHCMV vectors and uses thereof
App 20130136768 - Picker; Louis ;   et al.
2013-05-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed